2021 American Transplant Congress
Evaluation of a Weight-Based Mycophenolate Mofetil Dosing Protocol for Kidney Transplant Maintenance Immunosuppression
*Purpose: To evaluate the safety and efficacy of a weight-based mycophenolate mofetil (MMF) dosing protocol in adult kidney transplant recipients (KTR).*Methods: This single-center retrospective study…2021 American Transplant Congress
Pulmonary Infections in Patients with Kidney Transplant: Epidemiology, Risk Factors and Impact of a Dedicated Pre-Transplant Infectious Disease Consultation
Infectious Disease, APHP Henri Mondor, Créteil, France
*Purpose: We aim to describe the spectrum of pulmonary infections after kidney transplant, to identify risk factors and to evaluate the impact of pre transplant…2021 American Transplant Congress
Multi-drug Resistant Infections in Solid Organ Transplant Recipients, a New Era of Risk
University of Texas Medical Branch, Galveston, TX
*Purpose: Antibiotic drug resistant organisms (DRO) [extended spectrum beta-lactamase (ESBL), vancomycin-resistant enterococcus (VRE), and carbapenem resistant bacteria (CRB)] are becoming more prevalent and pose a…2021 American Transplant Congress
Methenamine for the Prevention of Recurrent UTIs Post-Renal Transplant
*Purpose: Urinary tract infections (UTIs) are a highly prevalent postoperative complication in kidney transplant recipients (KTRs), occurring in approximately 34% of patients. The common method…2021 American Transplant Congress
Cytomegalovirus Infection Among Adult Kidney Transplant Recipients: Findings From the USRDS-medicare Linked Database Study
*Purpose: Cytomegalovirus infection (CMVi) is a frequent complication and significant cause of morbidity and mortality after kidney transplantation (KT). However, there are limited recent national…2021 American Transplant Congress
Risk Factors for Mortality in Kidney Transplant Patients Infected by Sars-cov-2 in South of Spain
*Purpose: Covid-19 pandemic has especially affected kidney transplant (KT) recipients, who are more vulnerable than the general population due to their immunosuppressive status and added…2021 American Transplant Congress
Liver and Kidney Transplantation During the Covid-19 Pandemic Period: A Single Center Experience
*Purpose: Introduction: Beginning of this year, when the Covid-19 pandemic has first started, it had the immediate effect of severely reducing living and deceased organ…2021 American Transplant Congress
Propensity Matched Analysis of Death and Non-favorable Discharge Among Hospitalized Transplant Recipients with COVID-19
1Houston Methodist Research Institute, Houston, TX, 2Houston Methodist Hospital, Houston, TX
*Purpose: This study compared death and non-favorable discharge following a hospital admission for Coronavirus Disease 2019 (COVID-19) management for patients with a history of solid…2021 American Transplant Congress
T-Cell Exhaustion in EBV DNAemic Solid Organ Transplant Recipients
Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada
*Purpose: In transplant recipients, disease severity after infection with Epstein-Barr virus (EBV) may range from asymptomatic DNAemia to PTLD. Host factors likely play a key…2021 American Transplant Congress
Outcomes in High Risk CMV Liver Transplants with Elevated MELD Scores
*Purpose: There is inconclusive evidence on the impact of MELD score on CMV viremia after liver transplantation. Following the implementation of Share 35, liver transplant…
- « Previous Page
- 1
- …
- 22
- 23
- 24
- 25
- 26
- …
- 84
- Next Page »